According to HonorHealth, the previous method to detect pancreatic cancer by imaging and using blood levels of CA 19-9, a cancer antigen, has proved to be inadequate or misleading. The cancer doesn’t always produce detectable amounts of CA 19-9 in the earlier stages, leading to false negatives.
The new biomarker panel detects...
